371P A phase Ia/b, open-label, multicentre study of the TRAILR2 agonist BI 905711 in patients (pts) with advanced gastrointestinal (GI) cancers
| Autor: | Harding, J.J., Hofheinz, R.D., Elez Fernandez, M.E., Kuboki, Y., Rasco, D., Cecchini, M., Shen, L., Archuadze, S., Geng, J., Haderk, F., Pant, S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S706-S706 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|